Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

The major development of the past decade in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the introduction of cetuximab in combination with platinum plus 5-fluorouracil chemotherapy (CT), followed by maintenance cetuximab (the “E...

Descripción completa

Detalles Bibliográficos
Autores principales: Argiris, Athanassios, Harrington, Kevin J., Tahara, Makoto, Schulten, Jeltje, Chomette, Pauline, Ferreira Castro, Ana, Licitra, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422557/
https://www.ncbi.nlm.nih.gov/pubmed/28536670
http://dx.doi.org/10.3389/fonc.2017.00072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422557/
https://www.ncbi.nlm.nih.gov/pubmed/28536670
http://dx.doi.org/10.3389/fonc.2017.00072

Ejemplares similares